No, hydralazine should NOT be given PRN for SBP >140/90 mmHg
Hydralazine PRN for blood pressure 140/90 mmHg is inappropriate and potentially harmful—this blood pressure does not meet criteria for hypertensive emergency or urgency, and PRN antihypertensives should be reserved for true emergencies with target organ damage, not asymptomatic elevations.
Why This Practice Is Wrong
Blood Pressure Thresholds Matter
A BP of 140/90 mmHg represents stage 2 hypertension but does NOT constitute a hypertensive emergency or urgency 1, 2. Current guidelines define hypertensive emergencies as severe BP elevation (typically ≥180/110 mmHg) with acute target organ damage 2. Even hypertensive urgency requires BP ≥180/110 mmHg without target organ damage 3.
Evidence Against PRN Hydralazine Use
Real-world data demonstrates this practice is both common and problematic:
- In hospitalized patients, 36% of PRN antihypertensive doses were given for BP <180/110 mmHg, far below the threshold for acute intervention 4
- Only 2% of patients receiving IV hydralazine actually had urgent hypertensive conditions requiring such treatment 5
- 69% of IV hydralazine use lacked appropriate indications in one hospital system 6
Risks of Inappropriate Use
The FDA label warns that hydralazine can cause myocardial ischemia, myocardial infarction, and postural hypotension 7. Research confirms these concerns:
- Hypotension was the most common adverse event (occurring in 11 of 17 patients with adverse events) 5
- Rapid-acting antihypertensives for non-emergent hypertension produced excessive BP drops >80 mmHg in 18-20% of patients and MAP reductions >25% in 38-46%, potentially compromising cerebral blood flow 3
- IV hydralazine caused 13 mmHg lower MAP compared to no treatment, with highly variable responses 8
What Should Be Done Instead
For Asymptomatic BP 140/90 mmHg:
- Continue or optimize scheduled oral antihypertensives rather than using PRN medications
- Restart home antihypertensive regimens if they were inappropriately held (40.8% of patients receiving PRN medications had their home medications discontinued) 4
- Intensify the scheduled regimen if BP remains uncontrolled—62.4% of patients were discharged without regimen intensification despite needing PRN doses 4
Guideline-Directed Approach:
Current guidelines recommend combination therapy with scheduled medications (RAS blocker + CCB or diuretic) for confirmed hypertension ≥140/90 mmHg 2. The target is gradual BP control over days to weeks, not acute reduction 1, 2.
When IV Hydralazine IS Appropriate:
Reserve IV hydralazine for:
- Hypertensive emergencies with acute target organ damage (acute stroke, acute coronary syndrome, acute heart failure, eclampsia/preeclampsia)
- Pregnancy-related hypertension with SBP ≥170 or DBP ≥110 mmHg 2
Common Pitfalls to Avoid
- Don't confuse elevated BP readings with hypertensive emergencies—look for symptoms and end-organ damage
- Don't use PRN antihypertensives as a substitute for optimizing scheduled regimens
- Don't assume all BP elevations require immediate treatment—asymptomatic elevations in hospitalized patients often reflect undertreated chronic hypertension, not acute crises
- Recognize that BP variability is normal—single elevated readings don't require intervention at 140/90 mmHg
Quality Improvement Evidence
A targeted intervention reducing nonindicated IV hydralazine use (from 69% to 25%) through order set redesign and education demonstrates this practice can be successfully changed 6. Another QI initiative reduced inappropriate IV antihypertensive use from 11% to 7% of patients with asymptomatic elevated BP 9.
The bottom line: Treat chronic hypertension with scheduled oral medications, not PRN hydralazine. Reserve rapid-acting IV agents for true emergencies with target organ damage.